Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Apr 26, 2016

Merial Launches Combination Vaccine to Help Prevent Core Canine Diseases and Provide Comprehensive Leptospirosis Protection
- Photos 1
Apr 1, 2016

Sanofi and Regeneron Announce Positive Dupilumab Topline Results from Two Phase 3 Trials in Inadequately Controlled Moderate-to-Severe Atopic Dermatitis Patients

- Dupilumab is first systemic therapy to show positive Phase 3 results in patients with moderate-to-severe atopic dermatitis, a serious, chronic inflammatory skin disease marked by widespread rash, itching and associated psychosocial comorbidities -
Mar 30, 2016

Sanofi and Regeneron to Present Phase 3 Praluent^® (alirocumab) Injection Clinical Trial Data at ACC.16
Mar 29, 2016

Sanofi Pasteur Collaboration Uses Novel Technology towards Development of a 2nd Generation Influenza Vaccine

Pre-clinical immunogenicity and efficacy data published in Journal of Virology
Mar 16, 2016

Sanofi and Regeneron Strongly Disagree with U.S. Jury Verdict in Ongoing Patent Litigation Regarding Praluent® (alirocumab) Injection and Will Appeal

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.